Repurposing cefuroxime for treatment of COVID-19: a scoping review of <i>in silico</i> studies
Ashimiyu Durojaiye, John‐Ross D. Clarke, George Alexiades Stamatiades, Can Wang
Abstract
studies are required to evaluate the potential of Cefuroxime for COVID-19.Communicated by Ramaswamy H. Sarma.
Topics & Concepts
In silicoDrug repositioningCefuroximeRepurposingDrugMedicinePharmacologyCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Computational biologyIntensive care medicineBiologyAntibioticsDiseaseMicrobiologyInternal medicineInfectious disease (medical specialty)EcologyGeneBiochemistrySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesAntibiotic Resistance in Bacteria